4//SEC Filing
Lager Joanne Jenkins 4
Accession 0001209191-21-069136
CIK 0001808865other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 7:59 PM ET
Size
8.8 KB
Accession
0001209191-21-069136
Insider Transaction Report
Form 4
Lager Joanne Jenkins
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-10$4.30/sh+3,500$15,050→ 3,500 total - Exercise/Conversion
Stock Option (right to buy)
2021-12-10−3,500→ 203,438 totalExercise: $4.30Exp: 2025-06-11→ Common Stock (3,500 underlying) - Sale
Common Stock
2021-12-10$34.50/sh−3,500$120,750→ 0 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 23, 2021.
- [F2]One-fourth of the shares subject to the stock option vested on April 1, 2020. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816215
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 7:59 PM ET
- Size
- 8.8 KB